Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1

BACKGROUND: The current exploratory analysis was performed to evaluate the efficacy and safety of everolimus for treatment of human epidermal growth factor receptor 2-positive (HER2+) advanced breast cancer in the Asian subset of patients in the BOLERO-1 trial. METHODS: Postmenopausal women with HER...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer Res
Autors principals: Toi, Masakazu, Shao, Zhimin, Hurvitz, Sara, Tseng, Ling-Ming, Zhang, Qingyuan, Shen, Kunwei, Liu, Donggeng, Feng, Jifeng, Xu, Binghe, Wang, Xiaojia, Lee, Keun Seok, Ng, Ting Ying, Ridolfi, Antonia, Noel-baron, Florence, Ringeisen, Francois, Jiang, Zefei
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5387380/
https://ncbi.nlm.nih.gov/pubmed/28399902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-017-0839-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars